Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
128 | 23958 | 33.5 | 77% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BONE MARROW TRANSPLANTATION | journal | 1963424 | 15% | 42% | 3677 |
2 | HEMATOLOGY | WoSSC | 873496 | 58% | 5% | 13849 |
3 | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | journal | 810583 | 6% | 46% | 1391 |
4 | GRAFT VERSUS HOST DISEASE | authKW | 632351 | 5% | 45% | 1099 |
5 | TRANSPLANTATION | WoSSC | 459295 | 29% | 5% | 6915 |
6 | GVHD | authKW | 344593 | 2% | 51% | 528 |
7 | APLASTIC ANEMIA | authKW | 295625 | 2% | 48% | 486 |
8 | BUSULFAN | authKW | 224060 | 1% | 59% | 301 |
9 | HEMATOPOIETIC STEM CELL TRANSPLANTATION | authKW | 192922 | 2% | 26% | 586 |
10 | PERIPHERAL BLOOD STEM CELLS | authKW | 176600 | 1% | 62% | 223 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 873496 | 58% | 5% | 13849 |
2 | Transplantation | 459295 | 29% | 5% | 6915 |
3 | Immunology | 119894 | 34% | 1% | 8258 |
4 | Oncology | 77277 | 30% | 1% | 7268 |
5 | Cell & Tissue Engineering | 8888 | 2% | 2% | 448 |
6 | Medicine, Research & Experimental | 6466 | 7% | 0% | 1734 |
7 | Medicine, General & Internal | 1634 | 6% | 0% | 1333 |
8 | Pediatrics | 1242 | 4% | 0% | 846 |
9 | Surgery | 1207 | 6% | 0% | 1474 |
10 | Pathology | 644 | 2% | 0% | 526 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HEMATOL | 148102 | 10% | 5% | 2414 |
2 | BLOOD MARROW TRANSPLANT PROGRAM | 141348 | 1% | 43% | 261 |
3 | INT BLOOD MARROW TRANSPLANT | 99421 | 1% | 50% | 157 |
4 | BLOOD MARROW TRANSPLANTAT | 97084 | 1% | 27% | 282 |
5 | BONE MARROW TRANSPLANTAT | 76121 | 1% | 22% | 272 |
6 | BONE MARROW TRANSPLANT UNIT | 61702 | 1% | 29% | 167 |
7 | HEMATOL ONCOL | 53068 | 6% | 3% | 1336 |
8 | ALLOGENE STEM CELL TRANSPLANTAT | 51636 | 0% | 41% | 99 |
9 | HAEMATOL | 45590 | 3% | 4% | 825 |
10 | BONE MARROW TRANSPLANTAT UNIT | 44825 | 1% | 23% | 151 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BONE MARROW TRANSPLANTATION | 1963424 | 15% | 42% | 3677 |
2 | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 810583 | 6% | 46% | 1391 |
3 | BLOOD | 93727 | 7% | 5% | 1604 |
4 | EXPERIMENTAL HEMATOLOGY | 76922 | 2% | 10% | 590 |
5 | BRITISH JOURNAL OF HAEMATOLOGY | 63882 | 3% | 6% | 829 |
6 | CYTOTHERAPY | 38692 | 1% | 14% | 224 |
7 | JOURNAL OF HEMATOTHERAPY | 37801 | 0% | 50% | 60 |
8 | TRANSFUSION | 36492 | 2% | 6% | 473 |
9 | INTERNATIONAL JOURNAL OF HEMATOLOGY | 33247 | 1% | 8% | 316 |
10 | TRANSPLANTATION | 32500 | 3% | 4% | 696 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GRAFT VERSUS HOST DISEASE | 632351 | 5% | 45% | 1099 | Search GRAFT+VERSUS+HOST+DISEASE | Search GRAFT+VERSUS+HOST+DISEASE |
2 | GVHD | 344593 | 2% | 51% | 528 | Search GVHD | Search GVHD |
3 | BONE MARROW TRANSPLANTATION | 303262 | 4% | 25% | 962 | Search BONE+MARROW+TRANSPLANTATION | Search BONE+MARROW+TRANSPLANTATION |
4 | APLASTIC ANEMIA | 295625 | 2% | 48% | 486 | Search APLASTIC+ANEMIA | Search APLASTIC+ANEMIA |
5 | BUSULFAN | 224060 | 1% | 59% | 301 | Search BUSULFAN | Search BUSULFAN |
6 | HEMATOPOIETIC STEM CELL TRANSPLANTATION | 192922 | 2% | 26% | 586 | Search HEMATOPOIETIC+STEM+CELL+TRANSPLANTATION | Search HEMATOPOIETIC+STEM+CELL+TRANSPLANTATION |
7 | PERIPHERAL BLOOD STEM CELLS | 176600 | 1% | 62% | 223 | Search PERIPHERAL+BLOOD+STEM+CELLS | Search PERIPHERAL+BLOOD+STEM+CELLS |
8 | UNRELATED DONOR | 172375 | 1% | 66% | 205 | Search UNRELATED+DONOR | Search UNRELATED+DONOR |
9 | ALLOGENEIC STEM CELL TRANSPLANTATION | 167753 | 2% | 36% | 369 | Search ALLOGENEIC+STEM+CELL+TRANSPLANTATION | Search ALLOGENEIC+STEM+CELL+TRANSPLANTATION |
10 | CORD BLOOD TRANSPLANTATION | 161706 | 1% | 60% | 211 | Search CORD+BLOOD+TRANSPLANTATION | Search CORD+BLOOD+TRANSPLANTATION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | FIUZA-LUCES, C , GARATACHEA, N , SIMPSON, RJ , BERGER, NA , RAMIREZ, M , LUCIA, A , (2015) UNDERSTANDING GRAFT-VERSUS-HOST DISEASE. PRELIMINARY FINDINGS REGARDING THE EFFECTS OF EXERCISE IN AFFECTED PATIENTS.EXERCISE IMMUNOLOGY REVIEW. VOL. 21. ISSUE . P. 80 -112 | 259 | 66% | 7 |
2 | KANAKRY, CG , FUCHS, EJ , LUZNIK, L , (2016) MODERN APPROACHES TO HLA-HAPLOIDENTICAL BLOOD OR MARROW TRANSPLANTATION.NATURE REVIEWS CLINICAL ONCOLOGY. VOL. 13. ISSUE 1. P. 10 -24 | 111 | 78% | 10 |
3 | FERRARA, JLM , LEVINE, JE , REDDY, P , HOLLER, E , (2009) GRAFT-VERSUS-HOST DISEASE.LANCET. VOL. 373. ISSUE 9674. P. 1550-1561 | 93 | 73% | 685 |
4 | GIRALT, S , COSTA, L , SCHRIBER, J , DIPERSIO, J , MAZIARZ, R , MCCARTY, J , SHAUGHNESSY, P , SNYDER, E , BENSINGER, W , COPELAN, E , ET AL (2014) OPTIMIZING AUTOLOGOUS STEM CELL MOBILIZATION STRATEGIES TO IMPROVE PATIENT OUTCOMES: CONSENSUS GUIDELINES AND RECOMMENDATIONS.BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. VOL. 20. ISSUE 3. P. 295-308 | 124 | 78% | 41 |
5 | WOLFF, D , STEINER, B , HILDEBRANDT, G , EDINGER, M , HOLLER, E , (2009) PHARMACEUTICAL AND CELLULAR STRATEGIES IN PROPHYLAXIS AND TREATMENT OF GRAFT-VERSUS-HOST DISEASE.CURRENT PHARMACEUTICAL DESIGN. VOL. 15. ISSUE 17. P. 1974 -1997 | 178 | 75% | 19 |
6 | RUSSELL, JA , KANGARLOO, SB , (2008) THERAPEUTIC DRUG MONITORING OF BUSULFAN IN TRANSPLANTATION.CURRENT PHARMACEUTICAL DESIGN. VOL. 14. ISSUE 20. P. 1936-1949 | 140 | 94% | 36 |
7 | RESHEF, R , PORTER, DL , (2015) REDUCED-INTENSITY CONDITIONED ALLOGENEIC SCT IN ADULTS WITH AML.BONE MARROW TRANSPLANTATION. VOL. 50. ISSUE 6. P. 759 -769 | 119 | 84% | 9 |
8 | HO, VT , SOIFFER, RJ , (2001) THE HISTORY AND FUTURE OF T-CELL DEPLETION AS GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION.BLOOD. VOL. 98. ISSUE 12. P. 3192 -3204 | 155 | 73% | 235 |
9 | PAVLETIC, SZ , FOWLER, DH , (2012) ARE WE MAKING PROGRESS IN GVHD PROPHYLAXIS AND TREATMENT?.HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM. VOL. . ISSUE . P. 251-264 | 103 | 97% | 19 |
10 | KEKRE, N , ANTIN, JH , (2014) HEMATOPOIETIC STEM CELL TRANSPLANTATION DONOR SOURCES IN THE 21ST CENTURY: CHOOSING THE IDEAL DONOR WHEN A PERFECT MATCH DOES NOT EXIST.BLOOD. VOL. 124. ISSUE 3. P. 334 -343 | 82 | 98% | 35 |
Classes with closest relation at Level 2 |